Mangalam Drugs to hold 53rd AGM on Sep 23, 2026, for FY25-26.
Mangalam Drugs and Organics Limited will hold its 53rd AGM on September 23, 2026, to adopt FY25-26 financial statements and appoint auditors. The company will also ratify cost auditor remuneration and approve related party transactions. Remote e-voting is available from September 19-22, 2026.
The AGM is a significant corporate event that involves key decisions regarding financial statements, auditor appointments, and related party transactions, which can have a medium-term impact on the company's governance and operations.
The announcement is a routine corporate event (AGM notice) and does not contain any performance-related news or significant new developments that would sway the sentiment positively or negatively.
Mangalam Drugs and Organics Limited has announced the schedule for its 53rd Annual General Meeting (AGM) for the Financial Year 2025-26. The AGM will be held on Wednesday, September 23, 2026, at 03:00 P.M. IST through Video Conference/Other Audio-Visual Means, in accordance with relevant circulars from the Ministry of Corporate Affairs and SEBI.
The company will also submit its Annual Report for the Financial Year 2025-26, which includes the Notice convening the 53rd AGM. This report is being sent electronically to all shareholders whose email addresses are registered with the company or its Registrar & Share Transfer Agent or Depository Participant(s).
The agenda for the AGM includes the consideration and adoption of the Standalone and Consolidated Audited Financial Statements for the Financial Year ended March 31, 2026, along with the reports of the Board of Directors and Auditors. Additionally, Shri Govardhan Murlidhar Dhoot will be re-appointed as an Executive Director, having retired by rotation. The appointment of M/s. S.N. Nanda and Co., Chartered Accountants, as statutory auditors for a period of five consecutive years, is also on the agenda, subject to member approval.
Further, the remuneration of M/s. Rampurawala Mohammed A & Co. as Cost Auditors for FY 2026-27 will be ratified. The shareholders will also vote on approving material related party transactions for the period from the conclusion of the upcoming AGM until the conclusion of the AGM in the next financial year, with specified limits for each transaction. The appointment of M/s L. N. Joshi & Co. as Secretarial Auditors for a term of five years, commencing from the conclusion of the 53rd AGM, will also be proposed.
The cut-off date for remote e-voting is September 16, 2026. E-voting will commence on September 19, 2026, at 09:00 A.M. and conclude on September 22, 2026, at 05:00 P.M. The Annual Report and AGM Notice are available on the company's website and the NSDL e-voting website.
A plain-language summary of a public exchange filing by Mangalam Drugs And Organics Limited. Read the original for the full detail.